SEARCH

SEARCH BY CITATION

References

  • 1
    Kiely JL, Brett KM, Yu S, Rowley DL. Low birth weight and intrauterine growth retardation. In From Data to Action: CDC's Public Health Surveillance for Women, Infants, and Children, WilcoxLS, MarksJS (eds). U.S. Department of Health & Human Services, 1993; 185202.
  • 2
    McEwen BS. Protective and damaging effects of stress mediators: the good and bad sides of the response to stress. Metabolism 2002; 51: 24.
  • 3
    Paarlberg KM, Vingerhoets AJ, Passchier J, Dekker GA, Heinen AG, van Geijn HP. Psychosocial predictors of low birthweight: a prospective study. Br J Obstet Gynaecol 1999; 106: 834841.
  • 4
    Kochenour NK. Doppler velocimetry in pregnancy. Semin Ultrasound CT MR 1993; 14: 249266.
  • 5
    Adamson SL, Morrow RJ, Bascom PA, Mo LY, Ritchie JW. Effect of placental resistance, arterial diameter, and blood pressure on the uterine arterial velocity waveform: a computer modeling approach. Ultrasound Med Biol 1989; 15: 437442.
  • 6
    Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG. Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond) 2004; 106: 377382.
  • 7
    Hollis B, Prefumo F, Bhide A, Rao S, Thilaganathan B. First-trimester uterine artery blood flow and birth weight. Ultrasound Obstet Gynecol 2003; 22: 373376.
  • 8
    Bartha JL, Comino-Delgado R, Gonzalez-Mena C, Lopez I, Arrabal J. Umbilical blood flow and neonatal morphometry: a multivariate analysis. Eur J Obstet Gynecol Reprod Biol 1998; 79: 2733.
  • 9
    Teixeira JM, Fisk NM, Glover V. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ 1999; 318: 153157.
  • 10
    Kent A, Hughes P, Ormerod L, Jones G, Thilaganathan B. Uterine artery resistance and anxiety in the second trimester of pregnancy. Ultrasound Obstet Gynecol 2002; 19: 177179.
  • 11
    Sjostrom K, Valentin L, Thelin T, Marsal K. Maternal anxiety in late pregnancy and fetal hemodynamics. Eur J Obstet Gynecol Reprod Biol 1997; 74: 149155.
  • 12
    Florio P, Severi FM, Fiore G, Micheli L, Bocchi C, Nencini C, Pezzani I, Giorgi G, Petraglia F. Impaired uterine artery blood flow at mid gestation and low levels of maternal plasma corticotropin-releasing factor. J Soc Gynecol Investig 2003; 10: 294297.
  • 13
    Giles WB, McLean M, Davies JJ, Smith R. Abnormal umbilical artery Doppler waveforms and cord blood corticotropin-releasing hormone. Obstet Gynecol 1996; 87: 107111.
  • 14
    Pouta A, Hartikainen A, Sovio U, Gissler M, Laitinen J, McCarthy MI, Ruokonen A, Elliott P, Jarvelin M. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 2004; 43: 825831.
  • 15
    Dodic M, Moritz K, Wintour EM. Prenatal exposure to glucocorticoids and adult disease. Arch Physiol Biochem 2003; 111: 6169.
  • 16
    Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385396.
  • 17
    Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In The Social Psychology of Health: Claremont Symposium on Applied Social Psychology. SpacapanS, OskampS (eds). Sage: Newbury Park, CA, 1988; 3167.
  • 18
    Spielberger CD. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, 1983.
  • 19
    Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol 1978; 46: 932946.
  • 20
    James SA. John Henryism and the health of African-Americans. Cult Med Psychiat 1994; 18: 163182.
  • 21
    Kurmanavicius J, Florio I, Wisser J, Hebisch G, Zimmermann R, Muller R, Huch R, Huch A. Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation. Ultrasound Obstet Gynecol 1997; 10: 112120.
  • 22
    Jurkovic D, Ross D, Aslam N, Whitehead M. Diurnal variation in uterine artery blood flow in post-menopausal women on oestrogen hormone replacement therapy. Hum Reprod 1999; 14: 27162719.
  • 23
    Higgins KM, Davidian M, Giltinian DM. A two-step approach to measurement error in time-dependent covariates in nonlinear mixed-effect models, with application to IGF-1 pharmacokinetics. J Am Stat Assoc 1997; 92: 436448.
  • 24
    Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 1995; 80: 28882893.
  • 25
    Edwards A, Baker LS, Wallace EM. Changes in umbilical artery flow velocity waveforms following maternal administration of betamethasone. Placenta 2003; 24: 1216.
  • 26
    Sue-Tang A, Bocking AD, Brooks AN, Hooper S, White SE, Jacobs RA, Fraher LJ, Challis JR. Effects of restricting uteroplacental blood flow on concentrations of corticotrophin-releasing hormone, adrenocorticotrophin, cortisol, and prostaglandin E2 in the sheep fetus during late pregnancy. Can J Physiol Pharmacol 1992; 70: 13961402.
  • 27
    Rothman KJ, Greenland S. Modern Epidemiology. Lippincott-Raven: Philadelphia, 1998; 127133.
  • 28
    Maulik D. Doppler Ultrasound in Obsetrics & Gynecology. Springer: New York, 1997.